Veradigm (NASDAQ:MDRX) Shares Cross Above 200-Day Moving Average – Time to Sell?

Shares of Veradigm Inc. (NASDAQ:MDRXGet Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $4.65 and traded as high as $4.80. Veradigm shares last traded at $4.80, with a volume of 95,106 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded Veradigm to a “hold” rating in a report on Saturday, March 7th.

Read Our Latest Research Report on Veradigm

Veradigm Trading Up 3.2%

The stock has a market capitalization of $577.92 million, a PE ratio of 23.25 and a beta of 0.52. The company’s 50 day simple moving average is $4.52 and its 200 day simple moving average is $4.65.

Veradigm Company Profile

(Get Free Report)

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.

Featured Stories

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.